Stock listing

OTC:GBIM Globeimmune Inc Stock

Follow Globeimmune Inc into a list and get an email when it puts out news.

Share price · OTC:GBIM

$0.0001 USD 0.0000 (0.0%)

Close on Nov 11, 2026

Past year 0.0% · daily closes, Nov 11, 2025 – Nov 11, 2026, adjusted for splits
Day range
$0.0001 – $0.0001 USDNov 11, 2026
Volume
2,062 sharesNov 11, 2026
Market cap
$575 USDAt the close on Nov 11, 2026 · price × 5.75M shares outstanding
52-week range
$0.0001 – $0.0401 USDLowest and highest trades, Nov 12, 2025 – Nov 11, 2026
Traded on an average day
$0 USDMedian day 0 shares · 61 days with no trades · last 3 months, Aug 11, 2026 – Nov 11, 2026
Globeimmune Inc logo

Daily closes

Last 3 months, Aug 11, 2026 – Nov 11, 2026 · OTC:GBIM · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00010.00000.0%$0.0001$0.0001$0.00012,062
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.0001300
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000112,537
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00013,775
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.000135,900
$0.00010.00000.0%—$0.0001—756
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
$0.00010.00000.0%$0.0001$0.0001$0.00010
Ticker
OTC:GBIM
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

Globeimmune Inc on 6ix

Sector
Health care
Industry
Biotechnology
Decks
2 decks · latest Jun 30, 2014

Valuation

price Nov 11, 2026

Enterprise value
No statements on 6ix yet
P/E
No statements on 6ix yet
EV/sales
No statements on 6ix yet
EV/EBITDA
No statements on 6ix yet
Price/book
No statements on 6ix yet
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.00

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Globeimmune Inc · OTC:GBIMUS$575n/an/an/an/an/an/an/a0.00
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
CNBX Pharmaceuticals Inc. · OTC:CNBXUS$160,577US$151,090n/an/an/an/an/an/a1.78
Fifty 1 Labs Inc. · OTC:FITYUS$118,532US$282,021n/a6,000×n/an/an/an/a-1.17
GB Sciences, Inc. · OTC:GBLXUS$81,414US$2.07Mn/an/an/an/an/an/a-0.46
Lyra Therapeutics, Inc. · OTC:LYRAUS$53,246US$14.42Mn/a36.2×n/an/an/an/a0.67
ZyVersa Therapeutics, Inc. · OTC:ZVSAUS$810US$1.20Bn/an/an/an/an/an/a-0.56
Median of the othersUS$164,053US$159,19018.5×0.1×−382.1%1.3×1.14

Decks

DeckKindSlidesDate
IPO Roadshow (June 2014)IPO roadshow35 slidesJun 30, 2014
IPO Roadshow (June 2014)IPO roadshow28 slidesJun 12, 2014

Open Decks

Financials

Annual, in USD

Income statement

LineFY2022FY2021FY2020FY2019FY2015FY2014FY2013FY2012FY2011FY2010
Revenue6.46M5.97M22.5M14.6M5.11M4.07M
Cost of revenue2.65M4.99M9.02M10.0K
Gross profit3.81M974.2K13.5M14.6M5.11M4.07M
Research and development4.48M7.21M10.9M11.7M12.1M14.1M
Selling, general and administrative4.55M4.28M3.17M5.95M4.36M
Operating income-2.77M-5.82M7.69M-3.97M-12.6M-15.8M
Depreciation and amortization228.5K236.6K206.3K171.9K187.3K295.2K771.3K925.5K952.1K1.32M
EBITDA-2.58M-5.52M8.46M-3.04M-11.6M-14.4M
Interest expense03.89M1.90M0
Income before tax-2.77M-16.3M9.59M-2.01M-13.7M-14.8M
Income tax200.0K3.89M115.8K-1.95M1.13M-952.9K
Net income-2.77M-20.2M9.48M-2.01M-14.9M-14.8M
Earnings per share, basic-0.48-6.9199.11-21.07-155.37-154.69

Balance sheet

LineFY2015FY2014FY2013FY2012FY2011FY2010
Cash and equivalents9.90M16.8M5.92M2.00M15.2M20.3M
Short-term investments0000
Inventory0000
Current assets11.1M17.8M6.83M2.89M15.6M20.7M
Property, plant and equipment209.7K455.8K492.8K1.25M
Goodwill0000
Total assets11.5M18.4M7.42M4.24M17.7M23.7M
Accounts payable234.1K572.6K1.74M2.96M1.31M1.13M
Current liabilities4.23M5.17M6.41M8.35M13.4M6.40M
Long-term debt00198.0K0
Total debt921.0K
Total liabilities8.52M12.8M206.7M200.4M200.1M181.4M
Shareholders' equity2.99M5.60M-199.3M-196.1M-182.4M-157.7M
Shares outstanding5.75M2.91M95.6K95.6K95.6K95.6K

Cash flow

LineFY2015FY2014FY2013FY2012FY2011FY2010
Cash from operations-7.13M-10.1M3.93M-13.1M-5.01M-17.8M
Capital spending-35.7K-294.2K-12.2K-108.8K-132.8K-2.38M
Free cash flow-7.17M-10.3M3.92M-13.2M-5.14M-20.2M
Cash from investing218.0K-166.8K-12.2K-108.8K-132.8K-2.33M
Cash from financing021.1M1.80K25.2K1.02K17.9M
Dividends paid0000
Share buybacks0144.1M7.04M34.1M
Change in cash-6.91M10.9M3.92M-13.2M-5.14M-2.23M

Open Financials

Cap table

Built by 6ix from Globeimmune Inc’s releases

Common shares
5,751,574
Fully diluted
5,751,574

Fully diluted

LineShares
Common shares5,751,574

Share count over time

CountShares
Nov 22, 20265,751,574

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Augustine Lawlor
Other companies: PRF Technologies Ltd. (Director · Since at least Mar 18, 2026); Cypherpunk Technologies Inc. (Chief Operating Officer · Since at least Jan 20, 2017); Gyre Therapeutics, Inc. (Director · Aug 20, 2015 – Aug 31, 2023 · Past); Cardiovascular Systems Inc (Director · Aug 31, 2012 – Apr 27, 2023 · Past); Human Genome Sciences Inc (Director · Oct 10, 2011 – Jul 30, 2012 · Past)
Director · Jul 1, 2014 – Mar 18, 2016 · Past
Daniel J Mitchell
Other companies: Oruka Therapeutics, Inc. (Director · Feb 11, 2014 – Jan 30, 2024 · Past); Cardiovascular Systems Inc (Director · Jun 27, 2006 – Dec 12, 2008 · Past); Myogen Inc (Director · Feb 2, 2006 – Nov 17, 2006 · Past)
Director · Jul 1, 2014 – Mar 16, 2016 · Past
J William FreytagDirector · Jul 1, 2014 – Jul 9, 2015 · Past
Kirk A ChristoffersenVP, Corporate Development · Jul 1, 2014 – Aug 3, 2015 · Past
Pennina SaferDirector · Jul 1, 2014 – Sep 30, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Globeimmune Inc.